LAZARD ASSET MANAGEMENT LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$2,445
-1.3%
2,515,0000.0%0.00%0.0%
Q2 2023$2,476
-26.0%
2,515,000
-22.7%
0.00%
-25.0%
Q1 2023$3,344
+3277.8%
3,252,000
+3359.6%
0.00%
Q4 2022$99
-100.0%
94,000
-99.7%
0.00%
-100.0%
Q1 2021$36,314,000
+9.6%
35,799,000
+16.2%
0.04%
+4.8%
Q4 2020$33,127,000
-32.7%
30,799,000
-34.2%
0.04%
-39.1%
Q3 2020$49,225,000
+30.5%
46,799,000
+51.9%
0.07%
+19.0%
Q2 2020$37,715,000
+17.8%
30,799,000
+1.0%
0.06%
-1.7%
Q1 2020$32,022,000
-13.2%
30,485,000
-12.5%
0.06%
+11.3%
Q4 2019$36,879,000
+7.5%
34,825,0000.0%0.05%
-5.4%
Q3 2019$34,319,000
-5.3%
34,825,0000.0%0.06%
-5.1%
Q2 2019$36,239,000
+6.4%
34,825,000
+4.9%
0.06%
+5.4%
Q1 2019$34,050,000
+2.9%
33,200,0000.0%0.06%
-8.2%
Q4 2018$33,097,000
+75.0%
33,200,000
+87.6%
0.06%
+96.8%
Q3 2018$18,908,000
+278.7%
17,700,000
+254.0%
0.03%
+244.4%
Q4 2017$4,993,000
-63.6%
5,000,000
-63.0%
0.01%
-64.0%
Q3 2017$13,710,00013,500,0000.02%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2021
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 16,732,000$16,408,3851.23%
SONA ASSET MANAGEMENT (US) LLC 23,125,000$22,451,9230.93%
SSI INVESTMENT MANAGEMENT LLC 8,726,000$8,464,2200.69%
PFM Health Sciences, LP 15,000,000$14,587,5000.69%
RWC Asset Management LLP 10,000,000$9,709,0000.63%
Sonora Investment Management Group, LLC 6,245,000$6,108,1820.52%
Paloma Partners Management Co 10,006,000$9,733,2850.34%
MACKAY SHIELDS LLC 9,891,000$9,594,2700.26%
PALISADE CAPITAL MANAGEMENT, LP 8,704,000$8,455,0660.24%
Centiva Capital, LP 10,000,000$9,716,2880.21%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders